What it's actually good for
Here is the single most important thing to know about melatonin: you are almost certainly taking too much.
Walk into any pharmacy and the default melatonin dose is 5 mg, often 10 mg. Some gummies pack in 12 mg or more. Meanwhile, the physiological dose — the amount that raises your blood melatonin to normal nighttime levels — is about 0.3 mg. That means most commercial melatonin products deliver 10 to 30 times the amount your body would naturally produce. And the research consistently shows that more is not better.
Melatonin is not a sedative. It does not knock you out. It is a timing signal — a hormone your pineal gland releases in response to darkness to tell your body "it's time to sleep now." As a supplement, it works the same way: it shifts the clock, it doesn't force unconsciousness. That distinction matters for understanding both where it works and where it doesn't.
The evidence base is large and consistent. For two specific uses — falling asleep faster and managing jet lag — melatonin earns a genuine Grade A, backed by multiple meta-analyses and a Cochrane review. But the details matter, and the dose misconception leads a lot of people to either overdose and wake up groggy, or dismiss it as ineffective when a lower dose would have worked.
What the research says
Reducing sleep onset latency (Grade A)
A 2013 meta-analysis in PLoS One pooled 19 randomized controlled trials covering 1,683 participants and found that melatonin reduced the time to fall asleep by an average of about 7 minutes compared to placebo. It also increased total sleep time by roughly 8 minutes and improved subjective sleep quality scores. These effects were consistent across studies and statistically significant.
Seven minutes might sound modest, and it is. But the effect is reliable, and for people with delayed sleep phase — the "night owl" pattern where your internal clock runs late — melatonin's clock-shifting action is particularly valuable. It's also more effective in older adults, whose endogenous melatonin production naturally declines with age.
The key nuance: melatonin helps you fall asleep. It is less effective for staying asleep. If your problem is waking at 3 AM, an immediate-release melatonin at bedtime is unlikely to help. An extended-release formulation has more rationale for sleep maintenance, though the evidence base for that specific use is thinner.
Jet lag prevention and treatment (Grade A)
This is where melatonin's chronobiotic (clock-resetting) mechanism really shines. A Cochrane review of 10 RCTs found melatonin taken close to the target bedtime at the destination is remarkably effective for preventing or reducing jet lag, particularly when crossing five or more time zones traveling east. Doses of 0.5-5 mg were similarly effective — the 0.5 mg dose worked about as well as 5 mg.
The timing matters more than the dose: take it at the local bedtime of your destination, starting the day of arrival, for up to four days. This aligns your circadian rhythm to the new time zone.
Sleep in children and adolescents (Grade B)
A growing body of evidence supports melatonin use in children with neurodevelopmental conditions — particularly ADHD and autism spectrum disorder — who often have significant sleep-onset delay. Multiple RCTs show meaningful reductions in the time it takes these children to fall asleep. However, this gets a B rather than an A for several reasons: optimal pediatric dosing is less established, long-term safety data in developing brains is limited, and use should always be guided by a pediatrician. The American Academy of Pediatrics recommends behavioral interventions first.
What melatonin does not do
Melatonin is not a treatment for insomnia driven by anxiety, chronic pain, or sleep apnea. It won't keep you asleep if the underlying problem is untreated. It doesn't improve sleep architecture (deep sleep, REM) in a meaningful way. And it should not be used as a long-term crutch without investigating why you're not sleeping — sleep hygiene, light exposure, and underlying conditions matter more.
How much, and which form
Start low. The most effective approach, based on the dose-response research, is to start at 0.3-0.5 mg and increase only if needed. MIT research on low-dose melatonin demonstrated that 0.3 mg raises blood melatonin to normal nighttime physiological levels. Higher doses (3-5 mg) push levels far above normal, which can paradoxically reduce effectiveness by desensitizing melatonin receptors and causing residual next-day grogginess.
Timing. Take melatonin 30-60 minutes before your intended sleep time. This is non-negotiable — timing is the whole mechanism.
Form selection:
- Immediate-release (tablets, capsules): Best for difficulty falling asleep. The most studied form.
- Extended-release / sustained-release: More rationale for sleep maintenance (staying asleep), though less clinical evidence.
- Sublingual: Faster onset, bypasses first-pass liver metabolism. Useful if you want a quicker effect.
- Gummies: Popular but problematic — most contain 5-10 mg, far more than needed, and accuracy of dosing is harder to control.
- Liquid drops: Allow precise low dosing (0.3-0.5 mg), which is a real advantage given the evidence.
There is no RDA and no official upper limit, because melatonin is a hormone, not a nutrient. But the practical ceiling for most people is 1-3 mg. If you need more than that to fall asleep, melatonin is probably not addressing the actual problem.
Safety & interactions
Melatonin is generally well-tolerated for short-to-medium-term use. The most common side effects — morning grogginess, headache, vivid dreams — are dose-dependent and much less common at physiological doses (0.3-1 mg). Long-term safety data is limited but not alarming; some researchers consider low-dose use safe for extended periods.
A real concern that doesn't get enough attention: product quality is unreliable. A 2017 study in the Journal of Clinical Sleep Medicine tested 31 OTC melatonin supplements and found actual melatonin content ranged from 83% less to 478% more than what the label claimed. Even more concerning, 26% of products contained serotonin as a contaminant. This makes third-party testing essential.
Drug interactions to be aware of:
- Sedatives and CNS depressants (benzodiazepines, zolpidem, alcohol): additive sedation.
- Blood thinners (warfarin): melatonin has a mild antiplatelet effect.
- Immunosuppressants: melatonin has immunomodulatory properties — theoretical concern.
- Blood pressure medications: melatonin can affect blood pressure.
- Diabetes medications: may affect insulin sensitivity.
Use in children should be supervised by a pediatrician. This is informational, not medical advice — check with a clinician before starting, especially if pregnant, nursing, on medication, or managing a chronic condition.
How we picked the brand
Most melatonin products on the market fail on the most basic criterion: dose. We require a product that offers a low-dose option (0.3-1 mg), because the evidence is clear that higher doses are not more effective for most people. Beyond that, third-party testing is critical given documented issues with label accuracy and serotonin contamination. We look for clean formulations without unnecessary additives, from manufacturers with a track record of accurate labeling. (Specific brand pick pending a current test-pass verification — see frontmatter.)